“The role of EXPAREL as a sciatic nerve block in the popliteal fossa, particularly for pain control following foot and ankle procedures, is pivotal as clinical goals toward outpatient migration ...

“We are thrilled that today’s approval offers clinicians and patients another option for achieving long-lasting non-opioid pain control with Exparel ... A sciatic nerve block in the popliteal fossa is ...

“Importantly, this potential approval would give clinicians a safe and effective tool to provide 4 days of postsurgical pain control ... dose sciatic nerve block in the popliteal fossa for ...

Ultrasound-guided techniques also increased the success of specific blocks, such as brachial plexus nerve blocks, sciatic popliteal nerve block and brachial plexus axillary nerve blocks. Read the ...

The left popliteal, tibialis, and dorsalis pedis pulses were absent. The left ankle–brachial blood-pressure index was 0.3 (normal, 0.9 to 1.3), indicating the presence of severe peripheral ischemia.

to include administration in adults as an adductor canal block and a sciatic nerve block in the popliteal fossa. The approval is supported by data from 2 randomized, double-blind, active ...

as a single-dose sciatic nerve block in the popliteal fossa in patients undergoing bunionectomy. The results demonstrate that EXPAREL significantly improved pain control and reduced opioid ...